Terri B. Sebree

Insider Reports History

Entity
Individual
Location
Zynerba Pharmaceuticals, Inc., 80 W. Lancaster Avenue, Suite 300, Devon, PA
Signature
/s/ Albert P. Parker, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Terri B. Sebree:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Zynerba Pharmaceuticals, Inc. President Common Stock 0 $1.33 Oct 10, 2023 Direct
Zynerba Pharmaceuticals, Inc. President Stock Option (Right to Buy) 0 Oct 10, 2023 Direct

Insider Reports Filed by Terri B. Sebree

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ZYNE Zynerba Pharmaceuticals, Inc. Oct 10, 2023 4 $0 4 Oct 11, 2023 President
ZYNE Zynerba Pharmaceuticals, Inc. Sep 12, 2023 2 -$16.4K 4 Sep 14, 2023 President
ZYNE Zynerba Pharmaceuticals, Inc. Feb 7, 2023 2 -$5.95K 4 Feb 9, 2023 President
ZYNE Zynerba Pharmaceuticals, Inc. Jan 31, 2023 2 -$5.55K 4 Feb 2, 2023 President
ZYNE Zynerba Pharmaceuticals, Inc. Jan 23, 2023 2 -$14.7K 4 Jan 25, 2023 President
ZYNE Zynerba Pharmaceuticals, Inc. Jul 18, 2022 2 -$9.11K 4 Jul 20, 2022 President
ZYNE Zynerba Pharmaceuticals, Inc. Jan 26, 2022 2 $0 4 Jan 28, 2022 President